BGLC vs CTRA · rev $99.0K vs P/E 15, rev $5.46B
BioNexus Gene Lab Corp Common stock (BGLC) versus Coterra Energy Inc (CTRA) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Latest reported BGLC revenue for 2026-06-30 was $99.0K. Net income was -$830.0K. BGLC currently screens at market cap $6.1M.
Latest reported CTRA revenue for 2024-12-31 was $5.46B. Net income was $1.12B. Revenue was down 7.7% from 2023-12-31 to 2024-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
BGLC currently screens at market cap $6.1M. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
Not investment advice. Open the BGLC and CTRA stock pages for the full models.
Not investment advice.